Purchase Order 36C25026P0134

The Department of Veterans Affairs, Veterans Integrated Service Network 10, awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for the SAPIAN 3 Ultra Resilia 29mm Transcatheter Heart Valve. The contract was awarded on October 31, 2025, with an ultimate completion date of February 2, 2026, and carries no set-aside designation. The award represents a direct procurement of specialized cardiac medical devices for delivery to the VA facility in Irvine, California. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in structural heart disease treatment, serves as the sole source provider of this advanced transcatheter valve technology to the VA healthcare system.

This purchase order falls within the scope of Edwards Lifesciences LLC's broader relationship with the VA, which includes two significant five-year Indefinite Delivery Contracts valued at $2.5 million and $1.25 million respectively. These framework agreements establish the company as the primary supplier of advanced cardiac implants and devices across multiple Veterans Integrated Service Networks, enabling the VA to maintain critical short shelf-life medical devices on-site for veteran surgical procedures. The current award reflects ongoing procurement activities supporting the VA's cardiovascular care mission and reinforces Edwards Lifesciences LLC's established role as a critical partner in delivering specialized medical technologies to the federal veteran healthcare system.